Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Després JP.

Circulation. 1996 Aug 1;94(3):273-8.

2.

A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.

Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Després JP.

Can J Cardiol. 2001 Aug;17(8):859-65.

PMID:
11521128
3.

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

Couillard C, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ, Després JP.

Diabetes Care. 1998 May;21(5):782-6.

PMID:
9589240
4.

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.

Sweetnam PM, Bolton CH, Downs LG, Durrington PN, MacKness MI, Elwood PC, Yarnell JW.

Eur J Clin Invest. 2000 Nov;30(11):947-56.

PMID:
11114956
5.

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Circulation. 1997 Jan 7;95(1):69-75.

6.

Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Metabolism. 2000 Jan;49(1):53-61.

PMID:
10647064
7.

Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.

Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Després JP, Lamarche B.

Arch Intern Med. 2001 Nov 12;161(20):2474-80.

PMID:
11700160
8.

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1098-105.

9.

Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.

St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B.

Am J Cardiol. 2006 Apr 1;97(7):997-1001. Epub 2006 Feb 13.

PMID:
16563904
10.

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

Cantin B, Gagnon F, Moorjani S, Després JP, Lamarche B, Lupien PJ, Dagenais GR.

J Am Coll Cardiol. 1998 Mar 1;31(3):519-25.

11.

High-density lipoprotein-cholesterol and ischemic heart disease risk in Korean men with cardiac risk.

Linton JA, Kimm H, Ohrr H, Park IS, Jee SH.

Circ J. 2009 Jul;73(7):1296-301. Epub 2009 May 15.

12.

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

Jeppesen J, Hein HO, Suadicani P, Gyntelberg F.

Circulation. 1998 Mar 24;97(11):1029-36. Erratum in: Circulation 1998 May 19;97(19):1995.

13.
14.

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ.

N Engl J Med. 1996 Apr 11;334(15):952-7.

15.

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG.

J Am Coll Cardiol. 2003 Jun 4;41(11):1972-82.

16.

Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.

Koren-Morag N, Goldbourt U, Graff E, Tanne D.

J Neurol Sci. 2008 Jul 15;270(1-2):82-7. doi: 10.1016/j.jns.2008.02.005. Epub 2008 Apr 2.

PMID:
18377938
17.

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease.

St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Després JP, Lamarche B.

Circulation. 2001 Nov 6;104(19):2295-9.

18.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH.

N Engl J Med. 1991 Aug 8;325(6):373-81.

19.

Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up.

Stettler C, Suter Y, Allemann S, Zwahlen M, Christ ER, Diem P.

J Intern Med. 2006 Sep;260(3):272-80.

20.

Supplemental Content

Support Center